Cleanser — Technical Specification Overview

Key Technical Parameters #

When brand partners send us a cleanser brief, the first thing we do isn’t check the fragrance brief or the packaging mockup. We pull the spec sheet — or more often, notice there isn’t one. Cleanser formulation sits at an uncomfortable intersection: rinse-off contact time is short (typically 30–60 seconds), yet the formula has to perform across viscosity, foam, skin feel, pH, and preservation simultaneously. The specs that actually govern whether a cleanser will pass EU compliance, survive a 40°C accelerated stability run, and feel right to a consumer in Seoul or São Paulo are more specific than most briefs we receive. This article is a working reference for brand partners who want to understand what a complete cleanser technical specification looks like, what the numbers mean, and where the specification gaps that cause production failures actually live.

The Specification That Matters Most — and Why Most Specs Miss It #

Viscosity gets measured on every batch. pH gets checked. Those are the obvious ones. The parameter that actually controls downstream outcomes — and which we flag in our IQC-12 incoming material review procedure for every cleanser project — is surfactant active matter content, measured against ISO 2271, specifically as total active matter (TAM) expressed as % w/w at 20°C.

Here’s why it matters more than viscosity alone: a sodium laureth sulfate (SLES) blend coming in at 68% TAM versus 70% TAM changes your effective in-formula concentration by roughly 3% relative — which shifts foam volume, skin feel, and pH response simultaneously. If your viscosity target is 5,000–8,000 mPa·s (Brookfield RV, spindle 4, 10 rpm, 25°C), you can hit that number with different salt concentrations depending on TAM variation. The batch looks correct on the viscosity report. The foam collapses. The brand calls us. We pull the TAM data for that lot and there it is.

We’ve run internal audits across 23 SLES incoming lots over 18 months. Lot-to-lot TAM variation ranged from 67.4% to 71.1% — wider than most supplier COAs suggest. Two of those lots failed our foam height threshold of ≥ 90mm (cylinder method, 30 seconds, standardised hardness 150 ppm CaCO₃ water) despite passing the supplier’s own specification. At that point, you’re chasing foam with salt, and you’re in a formulation correction loop that delays launch by weeks.

The second most-underspecified parameter is rinse-off residue, which we assess gravimetrically. For gel cleansers, our internal acceptance threshold is ≤ 0.8 mg/cm² post-rinse under standardised water pressure and temperature. Most brands don’t include this in their spec at all. Then they get consumer feedback about “tacky skin” and assume it’s the moisturiser brief — it’s not.

Regulatory frameworks don’t specify TAM or rinse residue directly, but they set the boundary conditions. The EU Cosmetics Regulation 1223/2009 requires that product performance claims be substantiated, which means if you’re claiming “clean rinse” or “residue-free,” you need measurable data behind it. We link every cleanser specification we write to that standard, and to ISO Standards for the relevant test methods, precisely because an incomplete spec is a liability at audit.

Supplier Qualification — What to Request and What the Response Tells You #

When we qualify a new surfactant supplier, the first document request isn’t the COA — it’s the test method behind the COA. Ask for the TAM determination method with reference to ISO 2271 or equivalent, and ask for their inter-laboratory precision data. The response time alone tells you something. Suppliers with mature QC infrastructure send this within 48 hours. Suppliers who come back asking “what do you need that for?” — that’s a signal worth noting.

For amphoteric surfactants like cocamidopropyl betaine (CAPB), which is one of the more common mildness co-surfactants in our acid-exfoliation-technology compatible cleanser systems, we require DMAPA (3-dimethylaminopropylamine) residual content data per batch. CAPB can carry DMAPA as a synthesis byproduct — the SCCS Scientific Opinion on CAPB sets a limit of 1 ppm DMAPA in finished product. We’ve had incoming lots test clean at the raw material stage and then show elevated DMAPA in the finished formula under accelerated storage conditions. The mechanism isn’t fully understood. We flag it in every CAPB-containing brief, and we ask suppliers for retest data at 6-month intervals, not just on delivery.

For botanical extract suppliers — relevant when building cleanser lines with botanical-adaptogen-actives positioned claims — ask for microbial limits data per USP <61> or equivalent, not just a general “passes specification” statement. We’ve received extracts with total aerobic microbial count (TAMC) up to 10³ CFU/g, which is technically within cosmetic raw material tolerance but creates a challenge test headache in a low-preservative formula.

One counterintuitive point on supplier responses: a supplier who pushes back on your test method request, offers an alternative standard, and explains why their method has better precision for that matrix — that’s actually a good sign. It means they’ve thought about it. The ones who just say “yes to everything” without engaging technically are the ones who send you a different result at scale.

Cost-Performance Trade-offs in Cleanser Formulation #

The clearest trade-off we navigate on cleanser projects is between primary surfactant system cost and mildness profile. Conventional SLES/CAPB systems — the industry baseline — run at commodity pricing and deliver reliable, well-characterised performance. Amino acid-based surfactant systems (sodium lauroyl glutamate, sodium cocoyl glycinate, and their blends) cost roughly 4 to 8 times more per kilogram at current market rates, depending on grade and sourcing. That’s a real cost delta at 500kg batch scale.

The performance differential is measurable. A 2019 controlled study (n=30, 4-week repeated insult patch test design) comparing a sodium lauroyl glutamate-based wash at 15% active versus a matched SLES system showed a 38% reduction in transepidermal water loss (TEWL) elevation post-wash in the amino acid group. For a cleanser positioned at barrier-sensitive or barrier-repair-sensitive consumers, that number is defensible in a derm-tested claim. For a mass-market foaming wash with a $12 retail price point, the cost structure doesn’t work.

Where we push back on the premium surfactant brief: brands sometimes request amino acid surfactants specifically because they test well in consumer sensory panels — skin feels better, foam feels softer. But the same effect is achievable with a well-optimised SLES/CAPB/PEG-7 glyceryl cocoate blend at a fraction of the cost. We’ve achieved TEWL improvement parity in internal comparisons using optimised conventional systems versus entry-grade amino acid systems. The more expensive option isn’t always the better performing one. It depends heavily on the pH range you’re targeting and the rinse-off profile.

For oil cleansers and cleansing balms, the trade-off is different. The cost-driving variable is the emulsifier system, not the cleansing agent. Polyglyceryl-based emulsifiers that deliver clean phase inversion and no occlusive residue post-rinse are genuinely more expensive than PEG-derived alternatives. For EU and K-beauty positioning, the cost is usually justified. For other markets, it often isn’t. We try to be direct with brand partners about which market they’re actually formulating for before we start building the cost estimate.

Technical Deep-Dive: Cleanser Specification Matrix Across Formulation Archetypes #

This is where most spec gaps become visible. The table below reflects our internal specification benchmarks across three primary cleanser archetypes — foaming gel, cream/milk, and oil/balm — against seven parameters we consider non-negotiable in a production-ready spec. These are the thresholds we use as pass/fail criteria in our IQC-12 review before a formula progresses to pilot batch.

Acceptable ranges reflect the combination of formula type, regulatory market (EU/US baseline), and consumer sensory expectation. Where a cell shows a range, both ends represent formulation decisions, not failures.

A few things this table doesn’t fully capture. Foam height for cream cleansers isn’t a failure at 20mm — it’s intentional. Brands often brief us asking why the cream cleanser “doesn’t foam like a gel,” and we spend time in the kickoff call resetting that expectation. Low-foam isn’t a defect. It’s the spec.

The oil/balm viscosity range is the one we’re still refining. Anhydrous balm textures that emulsify on contact with water show viscosity readings that vary substantially with temperature and shear history. A reading of 55,000 mPa·s at 25°C can feel completely different to a consumer depending on whether the product is stored at 15°C in a German winter or 30°C in a Hong Kong summer. Our current approach is to supplement the viscosity spec with a penetrometry measurement, but we haven’t standardised the method across all grades yet. Our dataset will be cleaner after we complete testing on the four active balm projects running through our pilot line in Q3 2025.

The FDA Cosmetics Guidelines don’t mandate these specific parameters, but the product safety substantiation expectation under the Modernization of Cosmetics Regulation Act (MoCRA) means a clean, documented specification is increasingly necessary for US market products, even for OEM-manufactured SKUs. We’ve built MoCRA-readiness into our standard cleanser spec template as of early 2024.

Formulation Notes for Brand Partners #

When you brief us on a cleanser, the first questions we ask are: What market is this for? What’s the primary texture claim — foam, gel, cream, oil? And what does your consumer’s water quality look like?

That last question surprises people. Hard water (above 200 ppm CaCO₃) interacts with anionic surfactants and can cause foam collapse, residue, and pH drift. If your primary retail market is the Middle East or parts of the US, we adjust the surfactant blend and add chelating support accordingly. It changes the formula and the cost.

The most common brief mistake we see: brands request a “sulfate-free” formula and specify amino acid surfactants, but the budget reflects conventional surfactant pricing. We reframe this early. If sulfate-free is a genuine brand commitment, we scope two versions — one with amino acid primary surfactants and one using alkyl polyglucoside or betaine-forward blends — with cost comparison before we proceed. Picking the wrong surfactant system at brief stage and changing it at pilot costs four to six weeks.

Timeline on a standard cleanser project: lab samples in 2–3 weeks from confirmed brief, accelerated stability at 40°C/75%RH runs for 4–8 weeks, and 24-month real-time stability is initiated concurrently from the same pilot batch. Regulatory documentation for EU or US markets is prepared in parallel if that’s in scope.

Frequently Asked Questions #

Can we specify a pH of 4.0 for our acid-based cleansing gel?
A: Technically formulate-able, but pH 4.0 puts you at the edge of comfortable rinse-off sensory for most consumers — eyes stinging, mostly. More practically, drop below pH 4.5 and you start attracting EU regulatory attention depending on the active system, particularly if AHAs are present. Our standard range for gel cleansers is 4.5–5.5 and we rarely go below that without a specific clinical rationale.

Our supplier COA shows SLES passing spec — why did our batch fail foam testing?
A: COA pass/fail is only as good as the specification it’s tested against. If the supplier’s TAM acceptance range is ±2% and you received a lot at the low end of that range, you can be “in spec” and still miss our internal foam height threshold of ≥ 90mm. We’ve seen this pattern in about a third of out-of-spec foam complaints we investigate. The solution is to tighten your incoming TAM acceptance range to ±1% and run your own foam check on incoming lots — not just rely on the supplier’s certificate.

What happens to preservation in a low-pH gel cleanser?
A: Low pH actually helps your preservative system — most organic acid preservatives (benzoic acid, sorbic acid) work by protonation and are significantly more active below pH 5.0. The challenge is that some brands want the low pH benefit but also want to use preservative systems that perform better at neutral pH, like phenoxyethanol blends. That’s a tension we navigate per ISO 11930 challenge test results. We won’t release a formula to pilot without a passing Category A or B result — no exceptions.

What’s the minimum order quantity and how long does sampling take?
A: For a new cleanser development, MOQ at production scale is typically 300–500 kg depending on format and packaging. Lab development samples are bench-scale — 200–500g. Confirmed lab sample turnaround is 2–3 weeks from a complete brief, which means confirmed actives, target pH, texture direction, and market. Incomplete briefs push that timeline.

We’re launching in both the EU and South Korea — does that change the formula?
A: Yes, potentially. The EU EU Cosmetics Regulation 1223/2009 and Korean MFDS requirements share significant overlap but diverge on specific restricted substances and labelling. More practically, Korean consumers have distinct foam and skin feel expectations — richer, denser foam is more accepted there than in German markets, which affects your surfactant blend. We normally recommend specifying the two markets separately and deciding whether a single formula can serve both or whether a small variation is needed. Trying to force one formula to serve two sensory profiles without acknowledging the difference is where dual-market launches run into consumer reception problems. The formulation question is usually secondary to the sensory positioning question.

---

Have a product concept in mind? Contact our formulation team to request a complimentary brief review.